Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0096503 PROCESS OF POLYMERIZATION CATALYST PRODUCTION WITH CONTROLLED CATALYST PROPERTIES AND USE OF SAME IN OLEFIN...
Solid catalyst components for use in olefin polymerization, olefin polymerization catalyst systems containing the solid catalyst components, methods of making...
2017/0096502 METHODS OF PREPARING FUNCTIONALIZED POLYOLEFINS
Provided herein are methods for preparing a functionalized polyolefin from an unsaturated polyolefin containing one or more non-aromatic main-chain double...
2017/0096501 METHOD FOR PRODUCING HYDROGENATED PETROLEUM RESIN
A method for producing a hydrogenated petroleum resin by reacting dicyclopentadiene with a vinyl aromatic compound, subjecting the reaction product obtained by...
2017/0096500 SITE-SELECTIVE MODIFICATION OF POLYSACCHARIDES AND APPLICATIONS THEREOF
The present invention relates to site-selective modification of polysaccharides at their reducing end by conjugation with a single aminoxy-Regioselective...
2017/0096499 PROCESS FOR ACETYLATION OF WOOD IN THE PRESENCE OF AN ACETYLATION CATALYST
The present invention describes a process for the acetylation of wood comprising treating wood with an acetylation agent comprising acetic anhydride and/or...
2017/0096498 Animal Models and Therapeutic Molecules
The invention discloses methods for the generation of chimaeric human--non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so...
2017/0096497 USE OF ANTIBODY CONJUGATES
Provided herein are methods for inducing growth arrest or apoptosis in cancer cells in a subject. Further provided are methods of inhibiting or treating...
2017/0096496 ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
An human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human proprotein convertase subtilisin/kexin type 9...
2017/0096495 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In...
2017/0096494 POLYPEPTIDE STRUCTURAL MOTIFS ASSOCIATED WITH CELL SIGNALING ACTIVITY
Isolated polypeptides comprising or consisting essentially of specific structural motifs (e.g., three .beta.-sheets and two .alpha.-helices) are provided,...
2017/0096493 Anti Human Notch4 Antibody
The present invention provides an anti-human Notch4 antibody or a Notch4 binding fragment thereof that may have neutralizing activity against human Notch4, as...
2017/0096492 DOSAGE AND ADMINISTRATION OF ANTI-IGF-1R, ANTI-ErbB3 BISPECIFIC ANTIBODIES, USES THEREOF AND METHODS OF...
Provided herein are compositions comprising anti-IGF-1R, anti-ErbB3 bispecific antibodies alone or in combination with other anti-cancer agents. Also provided...
2017/0096491 HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)
A fully human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits human TNF-like ligand 1A (hTL1A) is provided. The...
2017/0096490 AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE...
The present invention relates to amino acid sequences that are directed against RANK-L, as well as to compounds or constructs, and in particular proteins and...
2017/0096489 ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF
The invention relates generally to variant activatable antibodies that include a masking moiety (MM), a cleavable moiety (CM), and an antibody (AB) that...
2017/0096488 HUMAN ANTIBODIES TO GFR ALPHA3 AND METHODS OF USE THEREOF
The present invention provides antibodies that bind to human GFR.alpha.3 and methods of using same. According to certain embodiments of the invention, the...
2017/0096487 ANTIBODIES SPECIFICALLY BINDING TO HER3
The present invention relates to isolated antibodies, or an antigen portions thereof, which bind to human HER3. The novel antibodies are of great utility since...
2017/0096486 AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER
The disclosure provides agents that inhibit granulin signalling for use as medicaments to reduce cancer stem cell activity in the treatment of cancer. The...
2017/0096485 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In...
2017/0096484 METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS
The present invention relates to methods of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive T cell. In...
2017/0096483 Biomarkers Related to Interleukin-33 (IL-33)-Mediated Diseases and Uses Thereof
The present invention relates to the identification of certain biomarkers for use in identifying patients who have, or are likely to develop an IL-33 mediated...
2017/0096481 SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
The present invention relates to polypeptides derived from single domain heavy chain antibodies directed to Tumor Necrosis Factor-alpha. It further relates to...
2017/0096480 ANTIBODY VARIANTS
Antibody variants of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and a binding...
2017/0096479 OPTIMIZED VARIANTS OF ANTI-VEGF ANTIBODIES
The present invention provides anti-VEGF antibodies and compositions that include anti-VEGF antibodies (e.g., antibody conjugates, fusion proteins, and...
2017/0096478 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE
The present invention relates to a therapeutic agent for inflammation in which histone is involved, the agent comprising a monoclonal antibody or an antigen...
2017/0096477 ANTI-GP73 MONOCLONAL ANTIBODIES AND METHODS OF OBTAINING THE SAME
Disclosed herein are antibodies and methods of using said antibodies to detect Golgi protein 73 (GP73) and fucosylated GP73 in a sample.
2017/0096476 METHODS AND COMPOSITIONS RELATED TO AMYLOID-BETA-42 OLIGOMERS
Embodiments are directed to compositions comprising a conformation-dependent antibody that specifically binds oligomeric A.beta.-42, and the methods of using...
2017/0096475 SINGLE DOMAIN BINDING MOLECULE
The present invention provides a single domain specific binding molecule having the structure FW1-CDR1-FW2-HV2-FW3a-HV4-FW3b-CDR3-FW4 in which the Framework...
2017/0096474 Antibodies that Neutralize Botulinum Neurotoxins
This disclosure provides antibodies that specifically bind to and typically neutralize botulinum neurotoxins (e.g., BoNT/A, BoNT/B, BoNT/E, etc.) and the...
2017/0096473 HUMAN PLACENTAL COLLAGEN COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME
The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and...
2017/0096472 ALBUMIN FUSION PROTEINS
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by...
2017/0096471 SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS
The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF.alpha. by...
2017/0096470 DUAL SPECIFIC BINDING PROTEINS HAVING A RECEPTOR SEQUENCE
Engineered multispecific binding proteins that bind at least one ligand for a receptor are provided, along with methods of making and uses in the prevention,...
2017/0096469 Bi-Specific Therapeutic Proteins for Tissue Repair
Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using...
2017/0096468 IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or...
2017/0096467 Peptide Analogs for Treating Diseases and Disorders
Provided herein are peptides, that in combination with metformin, are effective for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or...
2017/0096466 HOMOGENEOUS PREPARATIONS OF IL-31
Homogeneous preparations of human and murine IL-31 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding...
2017/0096465 FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE
Mutant fibroblast growth factor (FGF) proteins having a polypeptide sequence with a high sequence identity to proteins encoded by members of the Fgf-1...
2017/0096464 FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE
Mutant fibroblast growth factor (FGF) proteins having a polypeptide sequence with a high sequence identity to proteins encoded by members of the Fgf-1...
2017/0096463 Modified FGF-21 Polypeptides and Their Uses
Modified FGF-21 polypeptides and uses thereof are provided.
2017/0096462 CHIMERIC FGF21 PROTEINS WITH ENHANCED BINDING AFFINITY FOR BETA-KLOTHO FOR THE TREATMENT OF TYPE II DIABETES,...
The present invention relates to chimeric proteins that include an N-terminus coupled to a C-terminus, where the N-terminus includes an N-terminal portion of...
2017/0096461 Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other...
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
2017/0096460 HTT REPRESSORS AND USES THEREOF
Disclosed herein are Htt repressors and methods and compositions for use of these Htt repressors.
2017/0096459 PEPTIDE TAGS FOR LABELING PROTEINS BY FUSION, AND ANTIBODIES FOR THE DETECTION THEREOF
Peptide tags (tags) are provided for their fusion to proteins at the N-terminal or C-terminal ends, which are defined by a series of structural and functional...
2017/0096458 CYAA-BASED CHIMERIC PROTEINS COMPRISING A HETEROLOGOUS POLYPEPTIDE AND THEIR USES IN THE INDUCTION OF IMMUNE...
The invention relates to a chimeric protein comprising or consisting of, from N-terminal to C-terminal, (a) a N-terminal part of a Bordetella CyaA protein (b)...
2017/0096457 ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE
Disclosed herein are methods of treating or inhibiting inflammation in a subject by administering an anti-inflammatory protein to the subject. In some...
2017/0096456 IMMUNOGENIC HPV L2-CONTAINING VLPS AND RELATED COMPOSITIONS, CONSTRUCTS, AND THERAPEUTIC METHODS
The invention provides immunotherapeutic and prophylactic bacteriophage viral-like particle (VLPs) which are useful in the treatment and prevention of human...
2017/0096455 METHODS AND COMPOSITIONS FOR CHIMERIC CORONAVIRUS SPIKE PROTEINS
The present invention provides compositions and methods comprising a chimeric coronavirus spike protein.
2017/0096454 CYCLOHEPTAPEPTIDE AGENTS FOR TREATMENT OF CANCER AND OBESITY DISEASES
New anticancer and anti-obesity agents based on cyclic peptide compounds are isolated from the stem barks of Maytenus variabilis (Loes.) C. Y. Cheng...
2017/0096453 TEMPLATE-FIXED PEPTIDOMIMETICS
The template-fixed .beta.-hairpin peptidomimetics Cyclo(-Tyr-His-Cys-Ser-Ala-.sup.DPro-Dab-Arg-Tyr-Cys-Tyr-Gln-Lys-.sup.D-P- ro-Pro), disulfide bond between...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.